Individual risk profiling for breast cancer recurrence: towards tailored follow-up schemes

被引:14
作者
Kraeima, J. [1 ,2 ]
Siesling, S. [1 ,3 ]
Vliegen, I. M. H. [2 ]
Klaase, J. M. [4 ]
IJzerman, M. J. [1 ]
机构
[1] Univ Twente, Dept Hlth Technol & Serv Res HTSR, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands
[2] CTIT, CHOIR, NL-7500 AE Enschede, Netherlands
[3] Comprehens Canc Ctr Netherlands IKNL, Dept Registrat & Res, NL-3511 GD Utrecht, Netherlands
[4] Med Spectrum Twente, Dept Surg, NL-7500 KA Enschede, Netherlands
关键词
breast cancer; follow-up; locoregional recurrence; prognostic factor; personalised medicine; CLINICAL-PRACTICE GUIDELINES; CONSERVING THERAPY; TUMOR RECURRENCE; EORTC; 10801; MASTECTOMY; IMPACT; MAMMOGRAPHY; VALIDATION; CARE;
D O I
10.1038/bjc.2013.401
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Breast cancer follow-up is not tailored to the risk of locoregional recurrences (LRRs) in individual patients or as a function of time. The objective of this study was to identify prognostic factors and to estimate individual and time-dependent LRR risk rates. Methods: Prognostic factors for LRR were identified by a scoping literature review, expert consultation, and stepwise multivariate regression analysis based on 5 years of data from women diagnosed with breast cancer in the Netherlands in 2005 or 2006 (n = 17 762). Inter-patient variability was elucidated by examples of 5-year risk profiles of average-, medium-, and high-risk patients, whereby 6-month interval risks were derived from regression estimates. Results: Eight prognostic factors were identified: age, tumour size, multifocality, gradation, adjuvant chemo-, adjuvant radiation-, hormonal therapy, and triple-negative receptor status. Risk profiles of the low-, average-, and high-risk example patients showed non-uniform distribution of recurrence risks (2.9, 7.6, and 9.2%, respectively, over a 5-year period). Conclusion: Individual risk profiles differ substantially in subgroups of patients defined by prognostic factors for recurrence and over time as defined in 6-month time intervals. To tailor follow-up schedules and to optimise allocation of scarce resources, risk factors, frequency, and duration of follow-up should be taken into account.
引用
收藏
页码:866 / 871
页数:6
相关论文
共 50 条
  • [31] The changing landscape in radiotherapy for breast cancer: Lessons from long term follow-up in some European breast cancer trials
    Bartelink, Harry
    RADIOTHERAPY AND ONCOLOGY, 2016, 121 (03) : 348 - 356
  • [32] Standards for follow-up care of patients with breast cancer
    Peppercorn, J
    Partridge, A
    Burstein, HJ
    Winer, EP
    BREAST, 2005, 14 (06) : 500 - 508
  • [33] Breast cancer follow-up: Literature review and discussion
    Sheppard, Carmel
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2007, 11 (04) : 340 - 347
  • [34] Patient follow-up after treatment for breast cancer
    Classe, J. -M.
    Sentilhes, L.
    Jaffre, I.
    Mezzadri, M.
    Lefebvre-Lacoeuille, C.
    Dejode, M.
    Catala, L.
    Bordes, V.
    Dravet, F.
    Descamps, P.
    JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION, 2010, 39 (08): : F85 - F88
  • [35] Follow-up of women with early stage breast cancer
    Jefford M.
    Mann G.B.
    Nolte L.
    Russell L.
    Brennan M.
    Current Breast Cancer Reports, 2014, 6 (3) : 183 - 192
  • [36] Effectiveness of routine follow-up in the detection of contralateral breast cancer in young women with early breast cancer
    Koedijk, M. S.
    van der Sangen, M. J. C.
    Poortmans, P. M. P.
    van Mierlo-Jansen, P.
    van den Broek, W. T.
    Storck, B. H. M.
    Voogd, A. C.
    EJSO, 2013, 39 (11): : 1186 - 1191
  • [37] Applying Risk-Based Follow-Up Strategies on the Dutch Breast Cancer Population: Consequences for Care and Costs
    Draeger, Teresa
    Voelkel, Vinzenz
    Groothuis-Oudshoorn, Catharina G. M.
    Lavric, Miha
    Veltman, Jeroen
    Dassen, Anneriet
    Boersma, Liesbeth J.
    Witteveen, Annemieke
    Sonke, Gabe S.
    Koffijberg, Hendrik
    Siesling, Sabine
    VALUE IN HEALTH, 2020, 23 (09) : 1149 - 1156
  • [38] Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis
    Drukker, C. A.
    Elias, S. G.
    Nijenhuis, M. V.
    Wesseling, J.
    Bartelink, H.
    Elkhuizen, P.
    Fowble, B.
    Whitworth, P. W.
    Patel, R. R.
    de Snoo, F. A.
    van 't Veer, L. J.
    Beitsch, P. D.
    Rutgers, E. J. Th.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 148 (03) : 599 - 613
  • [39] Breast Cancer "Tailored Follow-up" in Italian Oncology Units: A Web-Based Survey
    Natoli, Clara
    Brocco, Davide
    Sperduti, Isabella
    Nuzzo, Antonio
    Tinari, Nicola
    De Tursi, Michele
    Grassadonia, Antonino
    Mazzilli, Lorenzo
    Iacobelli, Stefano
    Gamucci, Teresa
    Vici, Patrizia
    PLOS ONE, 2014, 9 (04):
  • [40] Pattern of follow-up care and early relapse detection in breast cancer patients
    Geurts, Sandra M. E.
    de Vegt, Femmie
    Siesling, Sabine
    Flobbe, Karin
    Aben, Katja K. H.
    van der Heiden-van der Loo, Margriet
    Verbeek, Andre L. M.
    van Dijck, Jos A. A. M.
    Tjan-Heijnen, Vivianne C. G.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 136 (03) : 859 - 868